Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 27 announcements

Share price
₹1,981.10
Market cap
₹2,196 Cr
Revenue (annual)
₹384.8 Cr
Net profit (annual)
₹41.48 Cr
P/E (TTM)
48.2×Sector 47.4×
Promoter holding
59.10%-5.53% QoQ
FII holding
1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Fund Raise 5Earnings Call 3Board Meeting Date 3Price Movement Clarification 2Other Announcement 2Financial Results 2Board Meeting Outcome 2Share Pledge 1Results Correction 1Regulatory Approval 1Management Change 1Capital Structure Change 1Business Update 1Annual General Meeting 1Acquisition 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

12:28 IST NSE
Other Announcement

Beta Drugs Other Announcement

Beta Drugs Limited submitted its quarterly Monitoring Agency Report for June 2026. The report tracks the utilization of Rs. 117.01 Crore raised via preferential issues.

Value
₹117.0 Cr
Read the filing ↗
12:06 IST NSE
Other Announcement

Beta Drugs Other Announcement

Beta Drugs Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and the name of the depositories substituted in the register of members within prescribed timelines. This is a routine regulatory filing with no material financial impact.

Read the filing ↗